CLINICAL_TRIALS
research
· 2026-01-07
Clinical Trial Update: Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes [NA]
Summary
A Dana-Farber Cancer Institute trial is evaluating whole-body MRI screening to detect primary tumors in children and adults with Li-Fraumeni Syndrome and other …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Li-Fraumeni Syndrome | NA | Status: ACTIVE_NOT_RECRUITING